[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3916 Introduced in House (IH)]
<DOC>
118th CONGRESS
1st Session
H. R. 3916
To amend the Public Health Service Act to reauthorize and improve the
National Breast and Cervical Cancer Early Detection Program for fiscal
years 2024 through 2028, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
June 7, 2023
Mr. Morelle (for himself and Mr. Fitzpatrick) introduced the following
bill; which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend the Public Health Service Act to reauthorize and improve the
National Breast and Cervical Cancer Early Detection Program for fiscal
years 2024 through 2028, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Screening for Communities to Receive
Early and Equitable Needed Services for Cancer Act of 2023'' or the
``SCREENS for Cancer Act of 2023''.
SEC. 2. FINDINGS.
Congress finds the following:
(1) In 2023, there will be more than 300,590 new cases of
invasive breast cancer and nearly 44,000 breast cancer deaths
in the United States.
(2) In 2023, there will be about 13,960 new cases of
invasive cervical cancer and about 4,310 deaths from cervical
cancer.
(3) Black women have the highest breast, cervical, and
uterine cancer death rates of all racial and ethnic groups and
are more likely to be diagnosed with triple-negative breast
cancer, a more aggressive form of cancer.
(4) Research shows that the COVID-19 pandemic was
associated with a decline of more than 3,900,000 breast cancer
screenings in 2020, as compared to 2019. Similarly, cervical
cancer screening utilization dropped by 90 percent in April
2020, relative to the prior year.
(5) Research suggests that those postponed breast
screenings appeared to disproportionately affect women of
color: Non-Hispanic White women had 17 percent fewer breast
cancer diagnoses, while the year-over-year decline was 53
percent for Asian women, 43 percent for Hispanic women, and 27
percent for Black women.
(6) The National Cancer Institute estimates that pandemic-
related disruptions or delays in breast care and screening are
expected to result in an excess of 2,500 breast cancer deaths
by 2030.
(7) Since its creation in 1991, the National Breast and
Cervical Cancer Early Detection Program (referred to in this
section as the ``NBCCEDP'') has provided lifesaving cancer
screening and diagnostic services to low-income, uninsured, or
underinsured women in all 50 States, the District of Columbia,
6 territories, and 13 Tribes or Tribal organizations.
(8) NBCCEDP seeks to reduce inequities in breast and
cervical cancer screening and diagnosis, placing special
emphasis on outreach to women who are members of racial or
ethnic minority groups, and those who are geographically or
culturally isolated.
(9) NBCCEDP has served more than 6,100,000 people and
provided more than 15,700,000 breast and cervical cancer
screening examinations.
(10) These screening exams have diagnosed nearly 76,000
invasive breast cancers and more than 24,000 premalignant
breast lesions, as well as more than 5,100 invasive cervical
cancers and 235,000 premalignant cervical lesions, of which 39
percent were high-grade.
(11) The program also provides public education, outreach,
patient navigation, and care coordination to increase breast
and cervical cancer screening rates and reach underserved
populations.
(12) Reauthorizing NBCCEDP will result in expanded
services, leading to more people being screened and more
cancers diagnosed at earlier stages.
SEC. 3. NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM.
Title XV of the Public Health Service Act (42 U.S.C. 300k et seq.)
is amended--
(1) in section 1501 (42 U.S.C. 300k)--
(A) in subsection (a)--
(i) in paragraph (2), by striking ``the
provision of appropriate follow-up services and
support services such as case management'' and
inserting ``that appropriate follow-up services
are provided'';
(ii) in paragraph (3), by striking
``programs for the detection and control'' and
inserting ``for the prevention, detection, and
control'';
(iii) in paragraph (4), by striking ``the
detection and control'' and inserting ``the
prevention, detection, and control'';
(iv) in paragraph (5)--
(I) by striking ``monitor'' and
inserting ``ensure''; and
(II) by striking ``; and'' and
inserting a semicolon;
(v) by redesignating paragraph (6) as
paragraph (9);
(vi) by inserting after paragraph (5), the
following:
``(6) to enhance appropriate support activities to increase
breast and cervical cancer screening such as patient
navigation, implementation of evidence-based or evidence-
informed strategies proven to increase breast and cervical
cancer screening in health care settings, and facilitating
access to health care settings;
``(7) to reduce disparities in incidents of and deaths due
to breast and cervical cancer in populations with higher than
average rates;
``(8) to ensure equitable access to screening and
diagnostic services and improve access for individuals who
encounter additional barriers to receiving services, including
due to various social determinants of health; and''; and
(vii) in paragraph (9), as so redesignated,
by striking ``through (5)'' and inserting
``through (8)''; and
(B) by striking subsection (d);
(2) in section 1503 (42 U.S.C. 300m)--
(A) in subsection (a)--
(i) in paragraph (1), by striking ``that,
initially'' and all that follows through the
semicolon and inserting ``that appropriate
breast and cervical cancer screening and
diagnostic services are provided based on
national recommendations; and'';
(ii) by striking paragraphs (2) and (4);
(iii) by redesignating paragraph (3) as
paragraph (2); and
(iv) in paragraph (2), as so redesignated,
by striking ``; and'' and inserting a period;
and
(B) by striking subsection (d);
(3) in section 1508(b) (42 U.S.C. 300n-4(b))--
(A) by striking ``1 year after the date of the
enactment of the National Breast and Cervical Cancer
Early Detection Program Reauthorization of 2007, and
annually thereafter,'' and inserting ``2 years after
the date of enactment of the Screening for Communities
to Receive Early and Equitable Needed Services for
Cancer Act of 2023, and every 5 years thereafter,'';
(B) by striking ``Labor and Human Resources'' and
inserting ``Health, Education, Labor, and Pensions'';
and
(C) by striking ``preceding fiscal year'' and
inserting ``preceding 2 fiscal years in the case of the
first report after the date of enactment of the
Screening for Communities to Receive Early and
Equitable Needed Services for Cancer Act of 2023 and
preceding 5 fiscal years for each report thereafter'';
and
(4) in section 1510(a) (42 U.S.C. 300n-5(a))--
(A) by striking ``and'' after ``2011,''; and
(B) by inserting ``, $275,000,000 for fiscal year
2024, $330,000,000 for fiscal year 2025, $385,000,000
for fiscal year 2026, $440,000,000 for fiscal year
2027, and $500,000,000 for fiscal year 2028'' before
the period at the end.
<all>